185 related articles for article (PubMed ID: 7621843)
1. Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma. ACROBATICS Research Group.
Gunn SD; Ayres JG; McConchie SM
Eur J Clin Pharmacol; 1995; 48(1):23-8. PubMed ID: 7621843
[TBL] [Abstract][Full Text] [Related]
2. A comparison of two long-acting beta-agonists, oral bambuterol and inhaled salmeterol, in the treatment of moderate to severe asthmatic patients with nocturnal symptoms. The French Bambuterol Study Group.
Wallaert B; Brun P; Ostinelli J; Murciano D; Champel F; Blaive B; Montané F; Godard P
Respir Med; 1999 Jan; 93(1):33-8. PubMed ID: 10464846
[TBL] [Abstract][Full Text] [Related]
3. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma.
Fugleholm AM; Ibsen TB; Laxmyr L; Svendsen UG
Eur Respir J; 1993 Nov; 6(10):1474-8. PubMed ID: 8112441
[TBL] [Abstract][Full Text] [Related]
5. Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma. Bambuterol Multicentre Study Group.
Kuusela AL; Marenk M; Sandahl G; Sanderud J; Nikolajev K; Persson B
Pediatr Pulmonol; 2000 Mar; 29(3):194-201. PubMed ID: 10686040
[TBL] [Abstract][Full Text] [Related]
6. One month treatment with the once daily oral beta 2-agonist bambuterol in asthmatic patients.
Persson G; Baas A; Knight A; Larsen B; Olsson H
Eur Respir J; 1995 Jan; 8(1):34-9. PubMed ID: 7744191
[TBL] [Abstract][Full Text] [Related]
7. Bambuterol: effective in nocturnal asthma.
Petrie GR; Chookang JY; Hassan WU; Morrison JF; O'Reilly JF; Pearson SB; Shneerson JM; Tang OT; Ning AC; Turbitt ML
Respir Med; 1993 Nov; 87(8):581-5. PubMed ID: 8290741
[TBL] [Abstract][Full Text] [Related]
8. Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects.
Midgren B; Melander B; Persson G
Chest; 1992 Apr; 101(4):1019-22. PubMed ID: 1348219
[TBL] [Abstract][Full Text] [Related]
9. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration.
D'Alonzo GE; Smolensky MH; Feldman S; Gnosspelius Y; Karlsson K
Chest; 1995 Feb; 107(2):406-12. PubMed ID: 7842769
[TBL] [Abstract][Full Text] [Related]
10. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
11. Bambuterol: effects of a new anti-asthmatic drug.
Pedersen BK; Laursen LC; Gnosspelius Y; Faurschou P; Weeke B
Eur J Clin Pharmacol; 1985; 29(4):425-7. PubMed ID: 3912186
[TBL] [Abstract][Full Text] [Related]
12. Salmeterol compared with slow-release terbutaline in nocturnal asthma. A multicenter, randomized, double-blind, double-dummy, sequential clinical trial. French Multicenter Study Group.
Brambilla C; Chastang C; Georges D; Bertin L
Allergy; 1994 Jul; 49(6):421-6. PubMed ID: 7915501
[TBL] [Abstract][Full Text] [Related]
13. Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice daily.
Persson G; Gnosspelius Y; Anehus S
Eur Respir J; 1988 Mar; 1(3):223-6. PubMed ID: 3384075
[TBL] [Abstract][Full Text] [Related]
14. One-year safety study with bambuterol once daily and terbutaline three times daily in 2-12-year-old children with asthma. The Bambuterol Multicentre Study Group.
Zarkovic JP; Marenk M; Valovirta E; Kuusela AL; Sandahl G; Persson B; Olsson H
Pediatr Pulmonol; 2000 Jun; 29(6):424-9. PubMed ID: 10821722
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the clinical efficacy and patient acceptability of terbutaline Turbuhaler and salbutamol Rotahaler, in adult patients with asthma.
Gioulekas D; Papakosta D; Vordoyianni P; Baloti H; Vamvalis C
Respir Med; 1996 Apr; 90(4):205-9. PubMed ID: 8736653
[TBL] [Abstract][Full Text] [Related]
16. Effects of budesonide and bambuterol on circadian variation of airway responsiveness and nocturnal symptoms of asthma.
Wempe JB; Tammeling EP; Postma DS; Auffarth B; Teengs JP; Koëter GH
J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):349-57. PubMed ID: 1356117
[TBL] [Abstract][Full Text] [Related]
17. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study.
Boulet LP; Laviolette M; Boucher S; Knight A; Hébert J; Chapman KR
J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):13-21. PubMed ID: 9003206
[TBL] [Abstract][Full Text] [Related]
18. Clinical-pharmacokinetic aspects of prolonged effect duration as illustrated by beta2-agonists.
Rosenburg J
Eur J Clin Pharmacol; 2002 Jul; 58(4):S1-21. PubMed ID: 12214578
[TBL] [Abstract][Full Text] [Related]
19. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol.
Scalabrin DM; Solé D; Naspitz CK
J Asthma; 1996; 33(6):407-15. PubMed ID: 8968295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
